Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06372865 (Darigabat) evoked pain study in healthy volunteers
NCT02238717Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of darigabat in pain (4 arms), sponsored by Pfizer. Primary endpoints: Thermal pain detection threshold, Ultra-violet light sensitized pain detection threshold and 3 more. Started Sep 2014; status: completed.
02
Drugs
darigabat
03
Conditions
pain
Beyond the preview
Go deeper on NCT02238717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238717.